Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR3C1 | P04150 | 19/20 | 0.53 |
| ▸ | NR3C2 | P08235 | 13/20 | 0.53 |
| ▸ | PGR | P06401 | 13/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 7/20 | 0.50 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.45 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL292311 | 0.95 | NR3C1 (0.59) | NR3C1NR3C2PGRCYP3A4HSP90AA1 | |
| SCHEMBL4037923 | 0.92 | NR3C1 (0.63) | NR3C1NR3C2PGRCYP3A4 | |
| SCHEMBL292779 | 0.90 | NR3C1 (0.64) | NR3C1NR3C2PGRCYP3A4 | |
| SCHEMBL290890 | 0.86 | NR3C1 (0.70) | NR3C1NR3C2PGRCYP3A4 | |
| SCHEMBL27748539 | 0.82 | NR3C1 (0.54) | NR3C1NR3C2PGRCYP3A4 | |
| SCHEMBL292122 | 0.81 | NR3C1 (0.67) | NR3C1NR3C2PGRCYP3A4 | |
| SCHEMBL447415 | 0.80 | NR3C1 (0.66) | NR3C1NR3C2PGRCYP3A4 | |
| SCHEMBL291658 | 0.80 | NR3C1 (0.70) | NR3C1NR3C2PGRCYP3A4 | |
| SCHEMBL676369 | 0.80 | NR3C1 (0.78) | NR3C1NR3C2PGRCYP3A4 | |
| SCHEMBL27781968 | 0.79 | NR3C1 (0.60) | NR3C1NR3C2PGRCYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2056799-A2 | COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING GLAUCOMA OR PROGRESSION THEREOF | Bausch & Lomb Incorporated (US) | 2009-05-13 | — | — | EP | disclosed |
| WO-2008027796-A2 | COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING GLAUCOMA OR PROGRESSION THEREOF | BAUSCH & LOMB INCORPORATED (US) | 2008-03-06 | — | — | WO | disclosed |